Smear-negative pulmonary tuberculosis in industrialized countries

Chest

Volumn 120, Issue 2, 2001, Pages 330-334

  Long, R ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

ACID FAST BACTERIUM; DISEASE COURSE; DISEASE TRANSMISSION; EDITORIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDUSTRIALIZATION; LUNG TUBERCULOSIS; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; RISK FACTOR; SPUTUM SMEAR;

EID: 0034825953     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.120.2.330     Document Type: Editorial

References (36)

1. Impact of human immunodeficiency virus on tuberculosis in developing countries
2. The yield of acid-fast bacilli from serial smears in routine microscopy laboratories
3. New tools for the diagnosis of tuberculosis: The perspective of developing countries
4. An approach to the problems of diagnosing and treating adult smear-negative pulmonary tuberculosis in high-HIV-prevalence settings in sub-Saharan Africa
5. A review of the diagnosis and treatment of smear-negative pulmonary tuberculosis
6. Preventing the nosocomial transmission of tuberculosis
7. Clinical predictors of tuberculosis as a guide for a respiratory isolation policy
8. Presumptive diagnosis and treatment of pulmonary tuberculosis based on radiographic findings
9. Diagnostic standards and classification of tuberculosis in adults and children
10. Quantitative studies of mycobacterial populations in sputum and saliva
11. Comparison of a radiometric method (Bactec) and conventional culture media for recovery of mycobacteria from smear-negative specimens
12. Comparative study of a biphasic culture system (Roche MB Check System) with a conventional egg medium for recovery of mycobacteria
13. Postsanitorium pattern of antituberculous drug resistance in Western Canada: Effect of outpatient care and immigration
14. New diagnostic tools for tuberculosis
15. Rapid diagnostic tests for tuberculosis: What is the appropriate use?
16. Use of clinical risk assessments in evaluation of nucleic acid amplification tests for HIV/tuberculosis
17. The role of clinical suspicion in evaluating a new diagnostic test for active tuberculosis: Results of a multi-center prospective trial
18. Assessing physicians' estimation of the probability of coronary artery disease
19. Rapid diagnostic tests for tuberculosis: Progress but no gold standard
20. Inactivation of mycobacterophage S29 using ferrous ammonium sulfate as a tool for the detection of viable Mycobacterium smegmatis and M. tuberculosis
21. Evaluation of a new rapid bacteriophage-based method for drug susceptibility testing of Mycobacterium tuberculosis
22. Evaluation of a reverse transcription-PCR and a bacteriophage-based assay for rapid phenotypic detection of rifampin resistance in clinical isolates of Mycobacterium tuberculosis
23. Effect of treatment on contagiousness of patients with active pulmonary tuberculosis
24. Early identification and isolation of inpatients at high risk for tuberculosis
25. Validity of a decision tree for predicting active pulmonary tuberculosis
26. Controlling tuberculosis in an urban emergency department: A rapid decision instrument for patient isolation
27. Implementation of an emergency department triage procedure for the detection and isolation of patients with active pulmonary tuberculosis
28. Tuberculosis and human immunodeficiency virus infection
29. Tuberculosis in patients with human immunodeficiency virus infection
30. A study of the characteristics and course of sputum smear-negative pulmonary tuberculosis
31. Acid-fast bacilli in sputum smears of patients with pulmonary tuberculosis
32. Smear-negative pulmonary tuberculosis
33. Contacts of cases of active pulmonary tuberculosis
34. A population-based survey of tuberculosis symptoms: How atypical are atypical presentations
35. Pulmonary tuberculosis treated with directly observed therapy: Serial changes in lung structure and function